U.S. Magnetic Resonance Angiography Market Size, Share & Trends Analysis Report By Technique (Contrast Enhanced MRA, Non-contrast Enhanced MRA), By Indication, By End Use, And Segment Forecasts, 2020 - 2027
This report can be delivered to the clients within 10-12 business days post order confirmation
U.S. Magnetic Resonance Angiography Market Growth & Trends
The U.S. magnetic resonance angiography market size is expected to reach USD 2.93 billion by 2027, based on a new report by Grand View Research, Inc., expanding at a CAGR of 4.9% from 2020 to 2027. Rising adoption of artificial intelligence (AI) based imaging techniques is expected to contribute to market growth over the forecast period. AI can assist in the detection of abnormal growths, such as tumors. Automatic detection improves the overall patient experience due to faster reporting.
In U.S., around four in ten adults suffer from at least one chronic disease, accounting for around 45% of the total population. Moreover, growing elderly population has given rise to a higher incidence rate of chronic diseases needing better diagnosis, which is anticipated to drive the demand for diagnostic imaging procedures, including magnetic resonance angiography (MRA), in the country. The presence of extensive private and public funding initiatives in U.S. is likely to contribute to market growth. Medicare covers MRI scans ordered by healthcare providers as part of a medical diagnosis.
Some of the patients experience anxiety due to claustrophobia and avoid MRI machines due to fear. Key players such as Philips, Siemens, and Hitachi have launched open bore designs for patients suffering from fear of enclosed spaces. In addition, these companies are offering devices with an audiovisual experience inside the machine to help patients relax while undergoing the procedures. MRI machines use no radiations while diagnosis, unlike CT machines. Hence, demand for MRI and MRA procedures is expected to grow over the coming years.
U.S. Magnetic Resonance Angiography Market Report Highlights
U.S. Magnetic Resonance Angiography Market Growth & Trends
The U.S. magnetic resonance angiography market size is expected to reach USD 2.93 billion by 2027, based on a new report by Grand View Research, Inc., expanding at a CAGR of 4.9% from 2020 to 2027. Rising adoption of artificial intelligence (AI) based imaging techniques is expected to contribute to market growth over the forecast period. AI can assist in the detection of abnormal growths, such as tumors. Automatic detection improves the overall patient experience due to faster reporting.
In U.S., around four in ten adults suffer from at least one chronic disease, accounting for around 45% of the total population. Moreover, growing elderly population has given rise to a higher incidence rate of chronic diseases needing better diagnosis, which is anticipated to drive the demand for diagnostic imaging procedures, including magnetic resonance angiography (MRA), in the country. The presence of extensive private and public funding initiatives in U.S. is likely to contribute to market growth. Medicare covers MRI scans ordered by healthcare providers as part of a medical diagnosis.
Some of the patients experience anxiety due to claustrophobia and avoid MRI machines due to fear. Key players such as Philips, Siemens, and Hitachi have launched open bore designs for patients suffering from fear of enclosed spaces. In addition, these companies are offering devices with an audiovisual experience inside the machine to help patients relax while undergoing the procedures. MRI machines use no radiations while diagnosis, unlike CT machines. Hence, demand for MRI and MRA procedures is expected to grow over the coming years.
U.S. Magnetic Resonance Angiography Market Report Highlights
- By technique, the non-contrast enhanced magnetic resonance angiography segment dominated the market in 2019 in terms of revenue as it is considered to be a safer alternative for patients who are pregnant or are suffering from kidney disorders
- The contrast enhanced MRA segment is expected to register the fastest CAGR over the forecast period as theyoffer a detailed image of the blood vessels as compared to the tissues or organs surrounding them
- The abdominal MRAs segment is expected to register a maximum CAGR from 2020 to 2027. Abdominal MRAs assist in the assessment and diagnosis of various vascular abnormalities and are performed for the examination of the lymph nodes, blood vessels, blood flow, and to investigate the cause of swelling or pain
- By end use, the hospitals segment dominated the market in 2019 in terms of revenue on account of increased demand for affordable diagnostic services. The imaging centers segment is expected to register the fastest CAGR from 2020 to 2027.
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation & Scope
1.1.1 Technique
1.1.2 Indication
1.1.3 End Use
1.1.4 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis (Model 1)
1.6.2 Volume price analysis (model 2)
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective -
1.8.2 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Technique
2.2.2 Indication
2.2.3 End Use
2.3 Competitive Insights
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation
3.2 Market Lineage Outlook
3.2.1 Parent Market Outlook
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Increase in target population and disease prevalence
3.3.1.2 Increasing adoption of AI-based imaging solutions
3.3.1.3 Increase in adoption of MRI techniques
3.3.1.4 Supportive regulations and adequate insurance coverage
3.3.2 Market Restraint Analysis
3.3.2.1 Adverse effects or allergies of contrast dyes (Safety concerns)
3.3.2.2 High cost of MRA procedures
3.4 U.S. Magnetic Resonance Angiography (MRA) Market: Business Environment Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.1.1 Threat of new entrants
3.4.1.2 Bargaining power of suppliers
3.4.1.3 Bargaining power of buyers
3.4.1.4 Competitive rivalry
3.4.1.5 Threat of substitutes
3.4.2 PESTEL Analysis
3.4.2.1 Political & Legal
3.4.2.2 Economic
3.4.2.3 Technological
3.5 Penetration & Growth Prospect Mapping
3.5.1 Penetration Analysis
3.6 Regulatory Scenario & Reimbursement Framework
3.7 Major Deals & Strategic Alliances Analysis
3.7.1 Mergers & acquisitions and joint ventures
3.7.2 Technology collaborations
CHAPTER 4 U.S. MAGNETIC RESONANCE ANGIOGRAPHY (MRA) MARKET: TECHNIQUE ANALYSIS
4.1 U.S. Magnetic Resonance Angiography (MRA) Technique Market Share Analysis, 2019 & 2027
4.2 U.S. Magnetic Resonance Angiography (MRA) Technique Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Technique Segment
4.3.1 Contrast Enhanced MRA
4.3.1.1 Contrast enhanced MRA market, 2016 - 2027 (USD Million)
4.3.2 Non-contrast Enhanced MRA
4.3.2.1 Non-contrast enhanced MRA market, 2016 - 2027 (USD Million)
CHAPTER 5 U.S. MAGNETIC RESONANCE ANGIOGRAPHY (MRA) MARKET: INDICATION ANALYSIS
5.1 U.S. Magnetic Resonance Angiography (MRA) Indication Market Share Analysis, 2019 & 2027
5.2 U.S. Magnetic Resonance Angiography (MRA) Indication Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Indication Segment
5.3.1 Abdomen
5.3.1.1 Abdomen MRA market, 2016 - 2027 (USD Million)
5.3.2 Lower Extremities
5.3.2.1 Lower extremities MRA market, 2016 - 2027 (USD Million)
5.3.3 Others
5.3.3.1 Others market, 2016 - 2027 (USD Million)
CHAPTER 6 U.S. MAGNETIC RESONANCE ANGIOGRAPHY (MRA) MARKET: END USE ANALYSIS
6.1 U.S. Magnetic Resonance Angiography (MRA) End Use Market Share Analysis, 2019 & 2027
6.2 U.S. Magnetic Resonance Angiography (MRA) End Use Market: Segment Dashboard
6.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the End Use Segment
6.3.1 Hospitals
6.3.1.1 Hospitals market, 2016 - 2027 (USD Million)
6.3.2 Imaging Centers
6.3.2.1 Imaging centers market, 2016 - 2027 (USD Million)
6.3.3 Ambulatory Surgical Centers & Other Healthcare Settings
6.3.3.1 Ambulatory surgical centers & other healthcare settings market, 2016 - 2027 (USD Million)
CHAPTER 7 COMPETITIVE ANALYSIS
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Strategic Framework/ Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
7.3 Vendor Landscape
7.3.1 Company market position analysis (Geographic presence, product portfolio, employee strength, etc.)
7.3.2 Market Ranking, 2019
7.4 Key Company Profiles: Manufacturers
7.4.1 GE Healthcare
7.4.1.1 Company overview
7.4.1.2 Financial performance
7.4.1.3 Product benchmarking
7.4.1.4 Strategic initiatives
7.4.2 Koninklijke Philips N.V.
7.4.2.1 Company overview
7.4.2.2 Financial performance
7.4.2.3 Product benchmarking
7.4.2.4 Strategic initiatives
7.4.3 Siemens Healthcare GmbH
7.4.3.1 Company overview
7.4.3.2 Financial performance
7.4.3.3 Product benchmarking
7.4.3.4 Strategic initiatives
7.4.4 Hitachi, Ltd.
7.4.4.1 Company overview
7.4.4.2 Financial performance
7.4.4.3 Product benchmarking
7.4.4.4 Strategic initiatives
7.4.5 Canon, Inc.
7.4.5.1 Company overview
7.4.5.2 Financial performance
7.4.5.3 Product benchmarking
7.4.5.4 Strategic initiatives
7.4.6 Shenzhen Anke Hi-Tech Co., Ltd.
7.4.6.1 Company overview
7.4.6.2 Financial performance
7.4.6.3 Product benchmarking
7.4.7 Time Medical Holding
7.4.7.1 Company overview
7.4.7.2 Financial performance
7.4.7.3 Product benchmarking
7.4.8 ASG Superconductors spa
7.4.8.1 Company overview
7.4.8.2 Financial performance
7.4.8.3 Product benchmarking
7.4.8.4 Strategic initiatives
7.4.9 Neusoft Corporation
7.4.9.1 Company overview
7.4.9.2 Product benchmarking
7.4.9.3 Strategic initiatives
7.4.10 Shimadzu Corporation
7.4.10.1 Company overview
7.4.10.2 Product benchmarking
7.4.11 ESAOTE SPA
7.4.11.1 Company overview
7.4.11.2 Financial performance
7.4.11.3 Product benchmarking
7.4.11.4 Strategic initiatives
7.4.12 AllTech Medical Systems
7.4.12.1 Company overview
7.4.12.2 Financial performance
7.4.12.3 Product benchmarking
7.4.12.4 Strategic initiatives
7.5 Key Company Profiles: Service Providers
7.5.1 Envision Radiology
7.5.1.1 Company overview
7.5.1.2 Service benchmarking
7.5.2 CentraCare
7.5.2.1 Company overview
7.5.2.2 Service benchmarking
7.5.3 Radiology Associates of Ocala
7.5.3.1 Company overview
7.5.3.2 Service benchmarking
7.5.4 Hunt Regional Healthcare
7.5.4.1 Company overview
7.5.4.2 Service benchmarking
7.5.5 Montgomery Radiology Associates
7.5.5.1 Company overview
7.5.5.2 Service benchmarking
7.5.6 Dignity Health
7.5.6.1 Company overview
7.5.6.2 Service benchmarking
7.5.6.3 Strategic initiatives
7.5.7 Cedars-Sinai
7.5.7.1 Company overview
7.5.7.2 Service benchmarking
7.5.8 Kalispell Regional Healthcare
7.5.8.1 Company overview
7.5.8.2 Service benchmarking
7.5.9 UVA Health, bnk
7.5.9.1 Company overview
7.5.9.2 Service benchmarking
7.5.10 Fairfax Radiology
7.5.10.1 Company overview
7.5.10.2 Service benchmarking
7.5.10.3 Strategic initiatives
7.5.11 Larchmont Medical Imaging
7.5.11.1 Company overview
7.5.11.2 Service benchmarking
7.5.12 Icahn School of Medicine at Mount Sinai
7.5.12.1 Company overview
7.5.12.2 Service benchmarking
7.5.13 Sansum Clinic
7.5.13.1 Company overview
7.5.13.2 Service benchmarking
7.5.14 Insight Medical
7.5.14.1 Company overview
7.5.14.2 Service benchmarking
7.5.15 ARA Diagnostic Imaging
7.5.15.1 Company overview
7.5.15.2 Service benchmarking
CHAPTER 8 RECOMMENDATIONS
CHAPTER 9 KOL COMMENTARY
1.1 Market Segmentation & Scope
1.1.1 Technique
1.1.2 Indication
1.1.3 End Use
1.1.4 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis (Model 1)
1.6.2 Volume price analysis (model 2)
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective -
1.8.2 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Technique
2.2.2 Indication
2.2.3 End Use
2.3 Competitive Insights
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation
3.2 Market Lineage Outlook
3.2.1 Parent Market Outlook
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Increase in target population and disease prevalence
3.3.1.2 Increasing adoption of AI-based imaging solutions
3.3.1.3 Increase in adoption of MRI techniques
3.3.1.4 Supportive regulations and adequate insurance coverage
3.3.2 Market Restraint Analysis
3.3.2.1 Adverse effects or allergies of contrast dyes (Safety concerns)
3.3.2.2 High cost of MRA procedures
3.4 U.S. Magnetic Resonance Angiography (MRA) Market: Business Environment Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.1.1 Threat of new entrants
3.4.1.2 Bargaining power of suppliers
3.4.1.3 Bargaining power of buyers
3.4.1.4 Competitive rivalry
3.4.1.5 Threat of substitutes
3.4.2 PESTEL Analysis
3.4.2.1 Political & Legal
3.4.2.2 Economic
3.4.2.3 Technological
3.5 Penetration & Growth Prospect Mapping
3.5.1 Penetration Analysis
3.6 Regulatory Scenario & Reimbursement Framework
3.7 Major Deals & Strategic Alliances Analysis
3.7.1 Mergers & acquisitions and joint ventures
3.7.2 Technology collaborations
CHAPTER 4 U.S. MAGNETIC RESONANCE ANGIOGRAPHY (MRA) MARKET: TECHNIQUE ANALYSIS
4.1 U.S. Magnetic Resonance Angiography (MRA) Technique Market Share Analysis, 2019 & 2027
4.2 U.S. Magnetic Resonance Angiography (MRA) Technique Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Technique Segment
4.3.1 Contrast Enhanced MRA
4.3.1.1 Contrast enhanced MRA market, 2016 - 2027 (USD Million)
4.3.2 Non-contrast Enhanced MRA
4.3.2.1 Non-contrast enhanced MRA market, 2016 - 2027 (USD Million)
CHAPTER 5 U.S. MAGNETIC RESONANCE ANGIOGRAPHY (MRA) MARKET: INDICATION ANALYSIS
5.1 U.S. Magnetic Resonance Angiography (MRA) Indication Market Share Analysis, 2019 & 2027
5.2 U.S. Magnetic Resonance Angiography (MRA) Indication Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Indication Segment
5.3.1 Abdomen
5.3.1.1 Abdomen MRA market, 2016 - 2027 (USD Million)
5.3.2 Lower Extremities
5.3.2.1 Lower extremities MRA market, 2016 - 2027 (USD Million)
5.3.3 Others
5.3.3.1 Others market, 2016 - 2027 (USD Million)
CHAPTER 6 U.S. MAGNETIC RESONANCE ANGIOGRAPHY (MRA) MARKET: END USE ANALYSIS
6.1 U.S. Magnetic Resonance Angiography (MRA) End Use Market Share Analysis, 2019 & 2027
6.2 U.S. Magnetic Resonance Angiography (MRA) End Use Market: Segment Dashboard
6.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the End Use Segment
6.3.1 Hospitals
6.3.1.1 Hospitals market, 2016 - 2027 (USD Million)
6.3.2 Imaging Centers
6.3.2.1 Imaging centers market, 2016 - 2027 (USD Million)
6.3.3 Ambulatory Surgical Centers & Other Healthcare Settings
6.3.3.1 Ambulatory surgical centers & other healthcare settings market, 2016 - 2027 (USD Million)
CHAPTER 7 COMPETITIVE ANALYSIS
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Strategic Framework/ Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
7.3 Vendor Landscape
7.3.1 Company market position analysis (Geographic presence, product portfolio, employee strength, etc.)
7.3.2 Market Ranking, 2019
7.4 Key Company Profiles: Manufacturers
7.4.1 GE Healthcare
7.4.1.1 Company overview
7.4.1.2 Financial performance
7.4.1.3 Product benchmarking
7.4.1.4 Strategic initiatives
7.4.2 Koninklijke Philips N.V.
7.4.2.1 Company overview
7.4.2.2 Financial performance
7.4.2.3 Product benchmarking
7.4.2.4 Strategic initiatives
7.4.3 Siemens Healthcare GmbH
7.4.3.1 Company overview
7.4.3.2 Financial performance
7.4.3.3 Product benchmarking
7.4.3.4 Strategic initiatives
7.4.4 Hitachi, Ltd.
7.4.4.1 Company overview
7.4.4.2 Financial performance
7.4.4.3 Product benchmarking
7.4.4.4 Strategic initiatives
7.4.5 Canon, Inc.
7.4.5.1 Company overview
7.4.5.2 Financial performance
7.4.5.3 Product benchmarking
7.4.5.4 Strategic initiatives
7.4.6 Shenzhen Anke Hi-Tech Co., Ltd.
7.4.6.1 Company overview
7.4.6.2 Financial performance
7.4.6.3 Product benchmarking
7.4.7 Time Medical Holding
7.4.7.1 Company overview
7.4.7.2 Financial performance
7.4.7.3 Product benchmarking
7.4.8 ASG Superconductors spa
7.4.8.1 Company overview
7.4.8.2 Financial performance
7.4.8.3 Product benchmarking
7.4.8.4 Strategic initiatives
7.4.9 Neusoft Corporation
7.4.9.1 Company overview
7.4.9.2 Product benchmarking
7.4.9.3 Strategic initiatives
7.4.10 Shimadzu Corporation
7.4.10.1 Company overview
7.4.10.2 Product benchmarking
7.4.11 ESAOTE SPA
7.4.11.1 Company overview
7.4.11.2 Financial performance
7.4.11.3 Product benchmarking
7.4.11.4 Strategic initiatives
7.4.12 AllTech Medical Systems
7.4.12.1 Company overview
7.4.12.2 Financial performance
7.4.12.3 Product benchmarking
7.4.12.4 Strategic initiatives
7.5 Key Company Profiles: Service Providers
7.5.1 Envision Radiology
7.5.1.1 Company overview
7.5.1.2 Service benchmarking
7.5.2 CentraCare
7.5.2.1 Company overview
7.5.2.2 Service benchmarking
7.5.3 Radiology Associates of Ocala
7.5.3.1 Company overview
7.5.3.2 Service benchmarking
7.5.4 Hunt Regional Healthcare
7.5.4.1 Company overview
7.5.4.2 Service benchmarking
7.5.5 Montgomery Radiology Associates
7.5.5.1 Company overview
7.5.5.2 Service benchmarking
7.5.6 Dignity Health
7.5.6.1 Company overview
7.5.6.2 Service benchmarking
7.5.6.3 Strategic initiatives
7.5.7 Cedars-Sinai
7.5.7.1 Company overview
7.5.7.2 Service benchmarking
7.5.8 Kalispell Regional Healthcare
7.5.8.1 Company overview
7.5.8.2 Service benchmarking
7.5.9 UVA Health, bnk
7.5.9.1 Company overview
7.5.9.2 Service benchmarking
7.5.10 Fairfax Radiology
7.5.10.1 Company overview
7.5.10.2 Service benchmarking
7.5.10.3 Strategic initiatives
7.5.11 Larchmont Medical Imaging
7.5.11.1 Company overview
7.5.11.2 Service benchmarking
7.5.12 Icahn School of Medicine at Mount Sinai
7.5.12.1 Company overview
7.5.12.2 Service benchmarking
7.5.13 Sansum Clinic
7.5.13.1 Company overview
7.5.13.2 Service benchmarking
7.5.14 Insight Medical
7.5.14.1 Company overview
7.5.14.2 Service benchmarking
7.5.15 ARA Diagnostic Imaging
7.5.15.1 Company overview
7.5.15.2 Service benchmarking
CHAPTER 8 RECOMMENDATIONS
CHAPTER 9 KOL COMMENTARY
LIST OF TABLES
TABLE 1 List of Secondary Sources
TABLE 1 List of Secondary Sources
LIST OF FIGURES
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 U.S. magnetic resonance angiography (MRA) market outlook, 2019
FIG. 9 Market trends & outlook
FIG. 10 U.S. magnetic resonance angiography (MRA) market segmentation
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Geriatric population in U.S.
FIG. 13 Market restraint relevance analysis (Current & future impact)
FIG. 14 Penetration & growth prospect mapping
FIG. 15 U.S. magnetic resonance angiography (MRA) technique market share analysis, 2019 & 2027 (USD Million)
FIG. 16 U.S. magnetic resonance angiography (MRA) technique market: Segment dashboard (USD Million)
FIG. 17 Contrast enhanced MRA market, 2016 - 2027 (USD Million)
FIG. 18 Non-contrast enhanced MRA market, 2016 - 2027 (USD Million)
FIG. 19 U.S. magnetic resonance angiography (MRA) indication market share analysis, 2019 & 2027 (USD Million)
FIG. 20 U.S. magnetic resonance angiography (MRA) indication market: Segment dashboard (USD Million)
FIG. 21 Abdomen MRA market, 2016 - 2027 (USD Million)
FIG. 22 Lower extremities MRA market, 2016 - 2027 (USD Million)
FIG. 23 Others market, 2016 - 2027 (USD Million)
FIG. 24 U.S. magnetic resonance angiography (MRA) end use market share analysis, 2019 & 2027 (USD Million)
FIG. 25 U.S. magnetic resonance angiography (MRA) end use market: Segment dashboard (USD Million)
FIG. 26 Hospitals market, 2016 - 2027 (USD Million)
FIG. 27 Imaging centers market, 2016 - 2027 (USD Million)
FIG. 28 Ambulatory surgical centers and other healthcare settings market, 2016 - 2027 (USD Million)
FIG. 29 Recent developments & impact analysis, by key market participants
FIG. 30 Strategic framework/ competition categorization (key innovators, market leaders, emerging players)
FIG. 31 Company market position analysis
FIG. 32 KOL Commentary
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 U.S. magnetic resonance angiography (MRA) market outlook, 2019
FIG. 9 Market trends & outlook
FIG. 10 U.S. magnetic resonance angiography (MRA) market segmentation
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Geriatric population in U.S.
FIG. 13 Market restraint relevance analysis (Current & future impact)
FIG. 14 Penetration & growth prospect mapping
FIG. 15 U.S. magnetic resonance angiography (MRA) technique market share analysis, 2019 & 2027 (USD Million)
FIG. 16 U.S. magnetic resonance angiography (MRA) technique market: Segment dashboard (USD Million)
FIG. 17 Contrast enhanced MRA market, 2016 - 2027 (USD Million)
FIG. 18 Non-contrast enhanced MRA market, 2016 - 2027 (USD Million)
FIG. 19 U.S. magnetic resonance angiography (MRA) indication market share analysis, 2019 & 2027 (USD Million)
FIG. 20 U.S. magnetic resonance angiography (MRA) indication market: Segment dashboard (USD Million)
FIG. 21 Abdomen MRA market, 2016 - 2027 (USD Million)
FIG. 22 Lower extremities MRA market, 2016 - 2027 (USD Million)
FIG. 23 Others market, 2016 - 2027 (USD Million)
FIG. 24 U.S. magnetic resonance angiography (MRA) end use market share analysis, 2019 & 2027 (USD Million)
FIG. 25 U.S. magnetic resonance angiography (MRA) end use market: Segment dashboard (USD Million)
FIG. 26 Hospitals market, 2016 - 2027 (USD Million)
FIG. 27 Imaging centers market, 2016 - 2027 (USD Million)
FIG. 28 Ambulatory surgical centers and other healthcare settings market, 2016 - 2027 (USD Million)
FIG. 29 Recent developments & impact analysis, by key market participants
FIG. 30 Strategic framework/ competition categorization (key innovators, market leaders, emerging players)
FIG. 31 Company market position analysis
FIG. 32 KOL Commentary
